Acute leptin treatment enhances functional recovery after spinal cord injury

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Fernández Martos, Carmen María ^a   González, Pau ^a   Rodriguez, Francisco Javier ^a  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ISOPROTEIN; LEPTIN; LEPTIN RECEPTOR; MYELIN; ANTIINFLAMMATORY AGENT; NEUROPROTECTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MACROPHAGE; MALE; MICROGLIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; SENSORY SYSTEM; SPINAL CORD INJURY; ANIMAL; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; INFLAMMATION; METABOLISM; NEURALGIA; PATHOLOGY; SPINAL CORD; TREATMENT OUTCOME; UPREGULATION; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTROCYTES; GENE EXPRESSION PROFILING; INFLAMMATION; LEPTIN; LOCOMOTION; MACROPHAGES; MALE; MICROGLIA; NEURALGIA; NEURONS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; RECEPTORS, LEPTIN; SPINAL CORD; SPINAL CORD INJURIES; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; UP-REGULATION;

EID: 84859987404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035594     Document Type: Article

References (67)

1. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271.
2. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532.
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
4. Friedman JM, Halaas JL, (1998) Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
5. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, et al. (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
6. Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, et al. (2005) PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 115: 951-958.
7. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG Jr, et al. (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413: 794-795.
8. Munzberg H, Bjornholm M, Bates SH, Myers MG Jr, (2005) Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62: 642-652.
9. Zhang EE, Chapeau E, Hagihara K, Feng GS, (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A 101: 16064-16069.
10. Bjorbaek C, Buchholz RM, Davis SM, Bates SH, Pierroz DD, et al. (2001) Divergent roles of SHP-2 in ERK activation by leptin receptors. J Biol Chem 276: 4747-4755.
11. Fujioka K, Patane J, Lubina J, Lau D, (1999) CSF leptin levels after exogenous administration of recombinant methionyl human leptin. Jama 282: 1517-1518.
12. Hwa JJ, Ghibaudi L, Compton D, Fawzi AB, Strader CD, (1996) Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice. Horm Metab Res 28: 659-663.
13. Shanley LJ, Irving AJ, Harvey J, (2001) Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 21: RC186.
14. Russo VC, Metaxas S, Kobayashi K, Harris M, Werther GA, (2004) Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 145: 4103-4112.
15. Weng Z, Signore AP, Gao Y, Wang S, Zhang F, et al. (2007) Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282: 34479-34491.
16. Zhang F, Wang S, Signore AP, Chen J, (2007) Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 38: 2329-2336.
17. Guo Z, Jiang H, Xu X, Duan W, Mattson MP, (2008) Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem 283: 1754-1763.
18. Carro EM, (2009) Therapeutic approaches of leptin in Alzheimer's disease. Recent Pat CNS Drug Discov 4: 200-208.
19. Greco SJ, Sarkar S, Johnston JM, Zhu X, Su B, et al. (2008) Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochem Biophys Res Commun 376: 536-541.
20. Greco SJ, Sarkar S, Johnston JM, Tezapsidis N, (2009) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem Biophys Res Commun 380: 98-104.
21. Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, et al. (2009) Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci Lett 455: 191-194.
22. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, et al. (2010) Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 19: 1155-1167.
23. Harvey J, (2010) Leptin: the missing link in Alzheimer disease? Clin Chem 56: 696-697.
24. Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, et al. (2009) Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis 16: 731-740.
25. Ghanizadeh A, (2011) Leptin as a new approach for treatment for autism and epilepsy, a hypothesis with clinical implications. Brain Dev 33: 92; author reply 92-93.
26. Knafo S, Choi D, (2008) Clinical studies in spinal cord injury: moving towards successful trials. Br J Neurosurg 22: 3-12.
27. Jones TB, McDaniel EE, Popovich PG, (2005) Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11: 1223-1236.
28. Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, et al. (2007) Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 320: 1002-1012.
29. Basso DM, Beattie MS, Bresnahan JC, (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12: 1-21.
30. McDonald JW, Sadowsky C, (2002) Spinal-cord injury. Lancet 359: 417-425.
31. Beattie MS, Hermann GE, Rogers RC, Bresnahan JC, (2002) Cell death in models of spinal cord injury. Prog Brain Res 137: 37-47.
32. Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, et al. (2005) Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol 168: 65-75.
33. Almad A, McTigue DM, (2010) Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord. J Comp Neurol 518: 785-799.
34. Ankeny DP, Popovich PG, (2009) Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 158: 1112-1121.
35. Spencer NF, Poynter ME, Im SY, Daynes RA, (1997) Constitutive activation of NF-kappa B in an animal model of aging. Int Immunol 9: 1581-1588.
36. Silver J, Miller JH, (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156.
37. Strauch ED, Yamaguchi J, Bass BL, Wang JY, (2003) Bile salts regulate intestinal epithelial cell migration by nuclear factor-kappa B-induced expression of transforming growth factor-beta. J Am Coll Surg 197: 974-984.
38. Davies JE, Tang X, Bournat JC, Davies SJ, (2006) Decorin promotes plasminogen/plasmin expression within acute spinal cord injuries and by adult microglia in vitro. J Neurotrauma 23: 397-408.
39. Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJ, (2004) Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 19: 1226-1242.
40. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, et al. (2005) Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 202: 145-156.
41. Cafferty WB, Gardiner NJ, Das P, Qiu J, McMahon SB, et al. (2004) Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 24: 4432-4443.
42. Jiao J, Huang X, Feit-Leithman RA, Neve RL, Snider W, et al. (2005) Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. Embo J 24: 1068-1078.
43. Bouret SG, Draper SJ, Simerly RB, (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304: 108-110.
44. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, et al. (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304: 110-115.
45. Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, et al. (2006) Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. J Biol Chem 281: 12950-12958.
46. Lim G, Wang S, Zhang Y, Tian Y, Mao J, (2009) Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119: 295-304.
47. Tian Y, Wang S, Ma Y, Lim G, Kim H, et al. (2011) Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain. Pain 152: 1263-1271.
48. Zimmermann M, (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429: 23-37.
49. Dominguez E, Mauborgne A, Mallet J, Desclaux M, Pohl M, (2010) SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci 30: 5754-5766.
50. Lindsey AE, LoVerso RL, Tovar CA, Hill CE, Beattie MS, et al. (2000) An analysis of changes in sensory thresholds to mild tactile and cold stimuli after experimental spinal cord injury in the rat. Neurorehabil Neural Repair 14: 287-300.
51. Brennan AM, Lee JH, Tsiodras S, Chan JL, Doweiko J, et al. (2009) r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans. Eur J Endocrinol 160: 173-176.
52. Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS, (2006) Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab 91: 2605-2611.
53. Chan JL, Wong SL, Mantzoros CS, (2008) Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity. Clin Pharmacokinet 47: 753-764.
54. Chan JL, Wong SL, Orlova C, Raciti P, Mantzoros CS, (2007) Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay. J Clin Endocrinol Metab 92: 2307-2311.
55. McLennan DN, Porter CJ, Edwards GA, Brumm M, Martin SW, et al. (2003) Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheep. Pharm Res 20: 1156-1162.
56. Banks WA, (2008) The blood-brain barrier as a cause of obesity. Curr Pharm Des 14: 1606-1614.
57. Fernandez-Martos CM, Gonzalez-Fernandez C, Gonzalez P, Maqueda A, Arenas E, et al. (2011) Differential expression of wnts after spinal cord contusion injury in adult rats. PLoS One 6: e27000.
58. Basso DM, (2004) Behavioral testing after spinal cord injury: congruities, complexities, and controversies. J Neurotrauma 21: 395-404.
59. Lankhorst AJ, ter Laak MP, van Laar TJ, van Meeteren NL, de Groot JC, et al. (2001) Effects of enriched housing on functional recovery after spinal cord contusive injury in the adult rat. J Neurotrauma 18: 203-215.
60. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, et al. (1999) Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol 158: 351-365.
61. Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH, (2001) Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma 18: 187-201.
62. Hamers FP, Koopmans GC, Joosten EA, (2006) CatWalk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 23: 537-548.
63. Kunkel-Bagden E, Dai HN, Bregman BS, (1993) Methods to assess the development and recovery of locomotor function after spinal cord injury in rats. Exp Neurol 119: 153-164.
64. DomBourian MG, Turner NA, Gerovac TA, Vemuganti R, Miranpuri GS, et al. (2006) B1 and TRPV-1 receptor genes and their relationship to hyperalgesia following spinal cord injury. Spine (Phila Pa 1976) 31: 2778-2782.
65. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL, (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
66. Dixon W, (1948) A method for obtaining and analysing sensitivity data. J Am Stat Assoc 48: 109-126.
67. Garcia-Alias G, Valero-Cabre A, Lopez-Vales R, Fores J, Verdu E, et al. (2006) Differential motor and electrophysiological outcome in rats with mid-thoracic or high lumbar incomplete spinal cord injuries. Brain Res 1108: 195-204.